Roche
ROG.SW
#36
Rank
NZ$547.04 B
Marketcap
NZ$681.88
Share price
2.19%
Change (1 day)
40.52%
Change (1 year)

Roche (ROG.SW) - Total debt

Total debt on the balance sheet as of June 2025 : NZ$72.14 Billion

According to Roche's latest financial reports the company's total debt is NZ$72.14 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Roche - Total debt on balance sheet (from 2006 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$71.36 B23.27%
2023-12-31NZ$57.89 B27.92%
2022-12-31NZ$45.25 B-13.23%
2021-12-31NZ$52.15 B115.29%
2020-12-31NZ$24.22 B1.43%
2019-12-31NZ$23.88 B-16.04%
2018-12-31NZ$28.44 B3.77%
2017-12-31NZ$27.41 B-13.46%
2016-12-31NZ$31.68 B-7.86%
2015-12-31NZ$34.38 B3.57%
2014-12-31NZ$33.19 B29.83%
2013-12-31NZ$25.57 B-21.93%
2012-12-31NZ$32.75 B-10.7%
2011-12-31NZ$36.67 B-12.03%
2010-12-31NZ$41.69 B-26.17%
2009-12-31NZ$56.46 B735.77%
2008-12-31NZ$6.75 B-14.68%
2007-12-31NZ$7.91 B-17.67%
2006-12-31NZ$9.61 B-10.55%
2005-12-31NZ$10.75 B-3.74%
2004-12-31NZ$11.16 B-41.27%
2003-12-31NZ$19.01 B-64.37%
2002-12-31NZ$53.36 B-25.27%
2001-12-31NZ$71.41 B17.14%
2000-12-31NZ$60.96 B17.68%
1999-12-31NZ$51.80 B8.65%
1998-12-31NZ$47.68 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$79.28 B 9.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$71.63 B-0.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$105.35 B 46.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$44.20 B-38.73%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
NZ$55.44 B-23.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$41.31 B-42.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Abbott Laboratories
ABT
NZ$22.40 B-68.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$94.51 B 31.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$33.48 B-53.58%๐Ÿ‡บ๐Ÿ‡ธ USA